These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11211620)

  • 1. Apolipoprotein A-I-derived amyloid in atherosclerosis. Its association with plasma levels of apolipoprotein A-I and cholesterol.
    Mucchiano GI; Jonasson L; Häggqvist B; Einarsson E; Westermark P
    Am J Clin Pathol; 2001 Feb; 115(2):298-303. PubMed ID: 11211620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta.
    Mucchiano GI; Häggqvist B; Sletten K; Westermark P
    J Pathol; 2001 Feb; 193(2):270-5. PubMed ID: 11180176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.
    van Eijk IC; de Vries MK; Levels JH; Peters MJ; Huizer EE; Dijkmans BA; van der Horst-Bruinsma IE; Hazenberg BP; van de Stadt RJ; Wolbink GJ; Nurmohamed MT
    Arthritis Rheum; 2009 May; 60(5):1324-30. PubMed ID: 19404933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.
    Tian L; Wu J; Fu M; Xu Y; Jia L
    Metabolism; 2009 May; 58(5):668-74. PubMed ID: 19375590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-I with severe hypercholesterolaemia.
    Boullier A; Hennuyer N; Tailleux A; Furman C; Duverger N; Caillaud JM; Castro G; Fievet C; Fruchart JC; Duriez P
    Clin Sci (Lond); 2001 Mar; 100(3):343-55. PubMed ID: 11222122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function.
    Kahraman S; Kiykim AA; Altun B; Gençtoy G; Arici M; Gulsun M; Erdem Y; Yasavul U; Turgan C; Cağlar S
    Clin Transplant; 2004 Jun; 18(3):288-94. PubMed ID: 15142050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of induced atherosclerosis in h-apo AI transgenic mice by overexpression of human apo AI in the aortic wall.
    Li H; Gu S; Cao X; Wang Z; She M
    Chin Med J (Engl); 2000 Jul; 113(7):657-61. PubMed ID: 11776042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential atherogenic roles of lipids, lipoprotein(a) and lipid peroxidation in preeclampsia.
    Bayhan G; Koçyigit Y; Atamer A; Atamer Y; Akkus Z
    Gynecol Endocrinol; 2005 Jul; 21(1):1-6. PubMed ID: 16048794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein A1-derived amyloid in human aortic atherosclerotic plaques.
    Westermark P; Mucchiano G; Marthin T; Johnson KH; Sletten K
    Am J Pathol; 1995 Nov; 147(5):1186-92. PubMed ID: 7485381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice.
    Navab M; Hama S; Hough G; Fogelman AM
    Circulation; 2003 Oct; 108(14):1735-9. PubMed ID: 14504179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential impact of plasma triglycerides on HDL-cholesterol and HDL-apo A-I in a large cohort.
    Tremblay AJ; Sniderman AD; Gagné C; Bergeron J; Couture P
    Clin Biochem; 2007 Jan; 40(1-2):25-9. PubMed ID: 17046732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice.
    Lewis KE; Kirk EA; McDonald TO; Wang S; Wight TN; O'Brien KD; Chait A
    Circulation; 2004 Aug; 110(5):540-5. PubMed ID: 15277327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between plasma lipid concentrations and HDL subclasses.
    Yang Y; Yan B; Fu M; Xu Y; Tian Y
    Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired plasma viscosity via increased cholesterol levels in peripheral occlusive arterial disease [correction of disase].
    Ercan M; Koksal C; Konukoglu D; Bozkurt AK; Onen S
    Clin Hemorheol Microcirc; 2003; 29(1):3-9. PubMed ID: 14561898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
    Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
    J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A; Brown BG; Deeb SS; Brunzell JD
    J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
    Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cholesteryl ester transfer protein, peroxisome proliferator-activated receptor alpha, apolipoprotein E, and apolipoprotein A-I polymorphisms on high-density lipoprotein cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I:A-II concentrations: the Prospective Epidemiological Study of Myocardial Infarction study.
    Do HQ; Nazih H; Luc G; Arveiler D; Ferrières J; Evans A; Amouyel P; Cambien F; Ducimetière P; Bard JM
    Metabolism; 2009 Mar; 58(3):283-9. PubMed ID: 19217440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Caucasian male with very low blood cholesterol and low apoA-II without evidence of atherosclerosis.
    Park SH; Kim JR; Park JE; Cho KH
    Eur J Clin Invest; 2007 Apr; 37(4):249-56. PubMed ID: 17373959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.